Ibex Biosciences
Biopharmaceutical company.
Based in MD
🤖
AI Overview
With $280K in lobbying spend across 9 quarterly filings, Ibex Biosciences is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2023 to 2024.
$280K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $180K |
| 2024 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Education, Foreign Relations, MED
- •Advocacy related to the development of therapies for various medical issues, particularly for the treatment of Malaria. Advocacy in support of federal funding for a GMP Facility related to biopharmace
- •Advocacy in support of federal funding for a GMP Facility related to biopharmaceutical development.
Related Analysis
Related Investigations
The 22,000% ROI
When lobbying spending yields outsized returns.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.